SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Directorate Change

1 Nov 2017 07:00

RNS Number : 1523V
Rentokil Initial PLC
01 November 2017
 

1 November 2017

 

Appointment of Non-Executive Director

 

Rentokil Initial plc (FTSE: RTO) today announces the appointment of Dr Linda Yueh to its Board as a Non-Executive Director with effect from 1 November 2017. Linda will also become a member of the Audit Committee, the Remuneration Committee and the Nomination Committee from this date.

 

Linda is Fellow in Economics at St Edmund Hall, Oxford University, and Adjunct Professor of Economics at the London Business School. She is also Visiting Senior Fellow at the London School of Economics and Political Science's foreign policy think tank, the IDEAS research centre, and was Visiting Professor of Economics at Peking University.

 

She also serves on the Policy Committee of the Centre for Economic Performance at the London School of Economics, and on the Advisory Board of The Official Monetary and Financial Institutions Forum.

 

Previously, she has been an advisor to the World Bank, the European Commission, the Asian Development Bank, the World Economic Forum at Davos, and the British Chambers of Commerce, among others. She has served as a Non-Executive Director of the FTSE-listed companies: JPMorgan Asian Investment Trust and Bailie Gifford's Scottish Mortgage Investment Trust. She spent her early career years as a lawyer in New York with Paul Weiss Rifkind Wharton & Garrison.

 

Commenting on the appointment, John McAdam, Chairman of Rentokil Initial, said:

 

"Linda has the combination of economic, legal and international experience to bring valuable perspective to the Board and the Company as it continues to grow and develop. I am delighted that she has decided to join us and, along with the rest of the Board, I look forward to working with her." 

 

There are no further details to be disclosed relating to Linda Yueh under Section 9.6.13 of the Listing Rules.

 

 

For further information please contact:

 

Rentokil Initial plc

Media

Malcolm Padley

07788 978199

Company Secretary

Daragh Fagan

01276 607444

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAWGGUUUUPMGQG
Date   Source Headline
29th Aug 20187:00 amRNSDirector/PDMR Shareholding
20th Aug 201812:44 pmRNSDirector/PDMR Shareholding
1st Aug 20183:12 pmRNSHolding(s) in Company
31st Jul 20187:00 amRNSInterim Results
27th Jul 20185:07 pmRNSHolding(s) in Company
5th Jul 20184:52 pmRNSHolding(s) in Company
5th Jul 201811:36 amRNSDirector Declaration
28th Jun 20184:10 pmRNSHolding(s) in Company
7th Jun 20185:16 pmRNSDirector Declaration
17th May 20184:12 pmRNSDirector/PDMR Shareholding
16th May 20187:00 amRNSNotice of Capital Markets Days
9th May 20185:40 pmRNSResult of AGM
4th May 20184:27 pmRNSDirector/PDMR Shareholding
2nd May 201810:52 amRNSDirector/PDMR Shareholding
1st May 20186:00 pmRNSDirector/PDMR Shareholding
30th Apr 20185:48 pmRNSDirector/PDMR Shareholding
26th Apr 20183:24 pmRNSHolding(s) in Company
25th Apr 20184:50 pmRNSHolding(s) in Company
24th Apr 20183:55 pmRNSHolding(s) in Company
24th Apr 201810:53 amRNSHolding(s) in Company
20th Apr 20184:09 pmRNSDirector/PDMR Shareholding
19th Apr 20184:32 pmRNSHolding(s) in Company
19th Apr 20187:00 amRNSQ1 Trading Update
5th Apr 201812:57 pmRNSHolding(s) in Company
5th Apr 201811:06 amRNSAnnual Financial Report
4th Apr 20186:01 pmRNSDirector/PDMR Shareholding
3rd Apr 20184:12 pmRNSBlock listing Interim Review
29th Mar 201811:55 amRNSTotal Voting Rights
27th Mar 20184:01 pmRNSHolding(s) in Company
27th Mar 201812:58 pmRNSAdditional Listing
8th Mar 20185:50 pmRNSDirector/PDMR Shareholding
1st Mar 20187:00 amRNSFinal Results
27th Dec 20177:00 amRNSDirector/PDMR Shareholding
20th Dec 20173:40 pmRNSDirector/PDMR Shareholding
22nd Nov 20174:30 pmRNSHolding(s) in Company
17th Nov 20177:00 amRNSIssue of new EUR400m bond
13th Nov 20174:35 pmRNSHolding(s) in Company
13th Nov 20177:00 amRNSPurchase of Vector Disease Acquisition LLC
7th Nov 20174:14 pmRNSHolding(s) in Company
6th Nov 20177:00 amRNSDirectorate Change
2nd Nov 20176:07 pmRNSHolding(s) in Company
1st Nov 20177:00 amRNSDirectorate Change
19th Oct 20177:00 amRNSQ3 Trading Update
2nd Oct 20173:26 pmRNSBlock listing Interim Review
21st Sep 20177:00 amRNSDirectorate Change
18th Sep 20177:00 amRNSDirectorate Change
22nd Aug 20173:34 pmRNSChange to Director's details
4th Aug 201711:57 amRNSDirector/PDMR Shareholding
31st Jul 20172:16 pmRNSDirector Declaration
27th Jul 20177:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.